-
TWELVE-MONTH ISCHEMIC STROKE RISK AFTER NON-CARDIOEMBOLIC ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK: A REAL-WORLD STUDY USING A REGIONAL ELECTRONIC HEALTH RECORD DATABASE IN CHINA
Aug 11, 2026, 17:16 PM -
WHEN THE COMPARISON BREAKS: UNANCHORED INDIRECT COMPARISON IN A RARE PAEDIATRIC CANCER
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF PET-GUIDED DE-ESCALATION FOR HER2 POSITIVE EARLY BREAST CANCER IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
UNIVERSAL MATERNAL IMMUNIZATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN BRAZIL: AN EXTENDED COST-EFFECTIVENESS ANALYSIS AT THE REGIONAL LEVEL
Aug 11, 2026, 17:16 PM -
THE ECONOMIC BURDEN OF SEIZURE EMERGENCIES IN SPAIN: RESULTS FROM A COST OF ILLNESS STUDY
Aug 11, 2026, 17:16 PM -
UNCOVERING THE HIDDEN COSTS OF AUTOMATIC BIOSIMILAR SUBSTITUTION THROUGH BESPOKE ECONOMIC MODELING APPROACH
Aug 11, 2026, 17:16 PM -
THE EFFECT OF EDUCATIONAL CAMPAIGNS AND PUBLIC FIGURES' CANCER DIAGNOSES ON PANCREATIC CANCER-RELATED ONLINE INFORMATION-SEEKING BEHAVIOR: A HUNGARIAN EXPERIENCE
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF RISANKIZUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF BIOLOGIC-FAILED CROHN'S DISEASE IN CHINA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ORAL NIRMATRELVIR-RITONAVIR IN PATIENTS AT HIGH RISK FOR PROGRESSION TO SEVERE COVID-19 IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
HOSPITAL COSTS OF TREATING INFANTILE-ONSET SMA PATIENTS WITH HIGH DOSE NUSINERSEN (50/28 MG) VS STANDARD DOSE NUSINERSEN (12/12 MG) IN ITALY
Aug 11, 2026, 17:16 PM -
ASSOCIATIONS BETWEEN BRONCHIECTASIS SYMPTOMS AND CLINICAL OUTCOMES: PROTOCOL FOR A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS FEASIBILITY ASSESSMENT
Aug 11, 2026, 17:16 PM -
SUPPORTING DECISION-GRADE CLINICAL BENCHMARKING FOR PERCUTANEOUS CORONARY INTERVENTION: RE-DEVELOPMENT AND TEMPORAL VALIDATION OF A NATIONAL RISK MODEL FOR POST-PCI MORTALITY
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF BLOOD-BRAIN BARRIER MODULATION ACROSS LUNG CANCER BRAIN METASTASIS TREATMENT PATHWAYS IN THE UK NHS
Aug 11, 2026, 17:16 PM -
VIGNETTE-DERIVED HEALTH STATE UTILITIES IN SCANDINAVIAN HTA ASSESSMENTS
Aug 11, 2026, 17:16 PM -
FIT FOR PREVENTION? VACCINES UNDER THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT FRAMEWORK: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ESTABLISHMENT OF THE IMPORTANCE OF AND MEANINGFUL CHANGE IN PHYSICAL ACTIVITY IN PATIENTS WITH CANCER CACHEXIA; A DHT-MEASURABLE CONCEPT
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF ACTISTM HIP SYSTEM AND KINCISETM 2 SYSTEM IN PATIENTS UNDERGOING PRIMARY TOTAL HIP ARTHROPLASTY IN SPAIN...
Aug 11, 2026, 17:16 PM -
CHANGES IN PHYSICAL AND COGNITIVE STATUS FOLLOWING HOSPITALIZATION FOR RESPIRATORY TRACT INFECTIONS IN OLDER ADULTS: A POPULATION-BASED STUDY USING JAPANESE ADMINISTRATIVE DATA
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS AND BUDGET IMPACT ANALYSIS FOR PIRTOBRUTINIB VERSUS IDELALISIB PLUS RITUXIMAB AS THIRD-LINE TREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN THE NETHERLANDS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF COENZYME Q10 ADDED TO LIFESTYLE MODIFICATION IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL
Aug 11, 2026, 17:16 PM
